LifeStance Health Group Inc. (NASDAQ:LFST) saw an upside of 0.13% to close Friday at $7.60 after adding $0.01 on the day. The 5-day average trading volume is 887,140 shares of the company’s common stock. It has gained $8.30 in the past week and touched a new high 1 time within the past 5 days. An average of 775,440 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 905,920.
LFST’s 1-month performance is -16.30% or -$1.63 on its low of $7.25 reached on 08/17/23. The company’s shares have touched a 52-week low of $4.22 and high of $10.50, with the stock’s rally to the 52-week high happening on 06/29/23. YTD, LFST has achieved 53.85% or $2.66 and has reached a new high 33 times. However, the current price is down -27.62% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
LFST stock investors last saw insider trading activity on Jul 06.Mullins Kevin Michael (Chief Development Officer) most recently sold 135,400 shares at $8.67 per share on Jul 06. This transaction cost the insider $1,173,918. Chief Development Officer, Mullins Kevin Michael, sold 150,000 shares at a price of $8.72 on Jul 05. Then, on Jul 03, Chief Development Officer Mullins Kevin Michael sold 54,600 shares at a price of $9.00 per share. This transaction amounted to $491,400.
Valuation Metrics
LFST stock has a beta of 1.05. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.99 while the price-to-book (PB) in the most recent quarter is 1.84.
LifeStance Health Group Inc.’s quick ratio for the period ended June 29 was 1.30, with the current ratio over the same period at 1.30. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.17, while the total debt to equity was 0.17. The trailing 12-month EBITDA margin is -15.93% while for the period ending June 29, LifeStance Health Group Inc.’s operating margin was -17.50%. The firm’s gross profit as reported stood at $237.02 million against revenue of $859.54 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -51.12% to -$45.48 million, while revenue of -$34.24 million was 24.71% off the previous quarter. Analysts expected LFST to announce -$0.09 per share in earnings in its latest quarter, but it posted -$0.13, representing a -44.40% surprise. EBITDA for the quarter stood at more than -$28.36 million. LFST stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 676.04 million, with total debt at $500.34 million. Shareholders hold equity totaling $378.0 million.
Let’s look briefly at LifeStance Health Group Inc. (LFST) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 20.55% to suggest the stock is trending oversold, with historical volatility in this time period at 38.92%.
The stock’s 5-day moving average is $7.77, reflecting a -6.86% or -$0.56 change from its current price. LFST is currently trading -13.83% above its 20-day SMA, +4.40% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -10.17% and SMA200 by+0.66%.
Stochastic %K and %D was 10.40% and 7.99% and the average true range (ATR) pointed at 0.35. The RSI (14) points at 27.66%, while the 14-day stochastic is at 15.56% with the period’s ATR at 0.35. The stock’s 9-day MACD Oscillator is pointing at -0.39 and -0.79 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for LifeStance Health Group Inc. (NASDAQ: LFST), TD Cowen downgraded it to a Market perform rating. They previously had an Outperform rating on the stock.
